A Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Osteoarthritis of the Knee
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, prospective, randomized study in which patients will be randomized to
1 of 4 treatment arms (3 active and 1 placebo).
Each patient will receive two doses of active medication or placebo, with study drug
administered intravenously (IV). The primary goal of the study is to assess the safety and
tolerability of repeat administrations of REGN475 compared to placebo in patients with
osteoarthritis (OA) of the knee.